FDA Adverse Event Injury Summary report: Y

UNKNOWN_ENTELLUSSPIROX_PRODUCT

MDR report key: 11679170 · Received April 16, 2021

Report

Report Number
3006345872-2021-00002
Event Type
Injury
Date Received
April 16, 2021
Date of Event
July 1, 2020
Report Date
August 10, 2021
Manufacturer
ENTELLUS MEDICAL, INC.
Product Code
NHB
PMA / PMN Number
K192661
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
TN, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 0

ADDITIONAL INFORMATION RECEIVED JUNE 25, 2021 REPORTED THE PATIENT HAS AN ODD TINGLING SENSATION ALONG WITH PERSISTENT VALVULAR COLLAPSE. THE PATIENT IS CONSIDERING ANOTHER SURGERY BUT WILL WAIT 12-18 MONTHS TO GIVE THE LATERA IMPLANT TIME TO BE ABSORBED. H3 OTHER TEXT: DEVICE WAS NOT RETURNED FOR ANALYSIS.

Description of Event or Problem · 0

A 64-YEAR OLD MALE PATIENT PRESENTED WITH IMPLANT REJECTION ON THE LEFT SIDE OF HIS NOSE APPROXIMATELY 2 MONTHS AFTER IMPLANT. THE IMPLANT SITE WAS RAISED AND INFLAMED AT THE FOR TIP. THE PATIENT WAS TREATED WITH AFRIN, SALINE RINSE AND A STEROID INJECTION. THE IMPLANT WAS EVENTUALLY REMOVED. IT WAS NOT RETURNED TO ENTELLUS FOR ANALYSIS. ADDITIONAL INFORMATION RECEIVED JUNE 25, 2021 REPORTED THE PATIENT HAS AN ODD TINGLING SENSATION ALONG WITH PERSISTENT VALVULAR COLLAPSE. THE PATIENT IS CONSIDERING ANOTHER SURGERY BUT WILL WAIT 12-18 MONTHS TO GIVE THE LATERA IMPLANT TIME TO BE ABSORBED.

Additional Manufacturer Narrative · 1

A SMALL PORTION OF THE DEVICE WAS RETURNED.

Description of Event or Problem · 1

A (B)(6) MALE PATIENT PRESENTED WITH IMPLANT REJECTION ON THE LEFT SIDE OF HIS NOSE APPROXIMATELY 2 MONTHS AFTER IMPLANT. THE IMPLANT SITE WAS RAISED AND INFLAMED AT THE FOR TIP. THE PATIENT WAS TREATED WITH AFRIN, SALINE RINSE AND A STEROID INJECTION. THE IMPLANT WAS EVENTUALLY REMOVED. IT WAS NOT RETURNED TO ENTELLUS FOR ANALYSIS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
575383 UNKNOWN_ENTELLUSSPIROX_PRODUCT NHB, LATERA ABSORBABLE NASAL NHB ENTELLUS MEDICAL, INC.

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention